Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new ...
A slew of rules is sitting at the White House awaiting the Biden administration’s sign-off before the FDA can issue them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback